On

OncoImmunology

OncoImmunology is a dynamic, high-profile, open access journal covering tumor immunology and immunotherapy, including basic and translational studies in solid and hematological malignancies, immune responses against cancer, cancer immunoediting and immune evasion, modern immunotherapies, and immunological effects of conventional anticancer therapies.

Looking to publish in OncoImmunology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology, Oncology
Impact Factor 6.3
Quartile Q1
Open Access Type Open
ISSN 2162-402X
eISSN 2162-402X
Invitation Only Yes
Cost Range Article Publishing Charge (APC) required for open access publication; institutional agreements, discounts, and waivers may reduce or cover the APC

Submission Instructions

OncoImmunology is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 5,000 words. Manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include keywords and a declaration of interest statement.
References References must not exceed 80. References may be in any consistent scholarly citation style or format. References must include complete bibliographic details and every entry must have a corresponding in-text citation.
Figures & Tables Figures and tables are limited to a combined maximum of 8, with additional figures or tables permitted as supplementary material. Figures and tables may be placed within the text or submitted as separate documents.
Reformat to OncoImmunology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 5,000 words. Manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include keywords and a declaration of interest statement.
References References may be in any style or format if a consistent scholarly citation format is used. References must include the author name or names, journal or book title, article or chapter title, year of publication, volume and issue where appropriate, and page numbers, and every bibliographic entry must have a corresponding in-text citation.
Figures & Tables A maximum of 6 figures and tables combined is permitted, with additional figures or tables allowed in supplementary material. Tables with captions must appear on individual pages, followed by figures and then figure captions as a list.
Reformat to OncoImmunology using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 200 words. Abstract must be unstructured.
Manuscript Manuscript must be ordered as title page, abstract, keywords, prior presentations of the work, main text with Introduction, Materials and Methods, Results, and Discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include 5 to 10 keywords and a declaration of interest statement.
References References must not exceed 30. References may be in any consistent scholarly citation style or format. References must include author name or names, journal or book title, article or chapter title, year of publication, volume and issue where appropriate, and page numbers, and every bibliographic entry must have a corresponding in-text citation.
Figures & Tables There must be no more than 3 display items in total, with additional figures or tables allowed as supplementary material. Figures and tables may be placed within the text or submitted as separate documents.
Reformat to OncoImmunology using Livewrite Premium

Recent Publications

Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes

Anne-Laure Mallard de La Varende, Marine Fidelle, Guido Kroemer, Laurence Zitvogel

10.1080/2162402x.2026.2748140
View Publication

Estradiol-associated extracellular signaling in the human breast in vivo identifies mast cells as tumor-supportive stromal mediators

Annelie Abrahamsson, Xingyue Wang, Wen Zhong, Charlotta Dabrosin

10.1080/2162402x.2026.2746847
View Publication

Targeting tumor-selective membrane-associated PCNA enables selective antibody–drug conjugate therapy

Muhammad Abu Ahmad, Nir Miriam Ungar-Malma, Alon Naumchik, Noy Machluf-Katz, Olga Radinsky, Sarah Adi Eisdorfer, Abedallh Gara, Yosef Istoyler, Irit Alon, Daniel Sevilla-Sanchez, Kerry S. Campbell, Bar Kaufman, Moshe Elkabets, Angel Porgador

10.1080/2162402x.2026.2740432
View Publication

A novel oncolytic peptide synergizing with immunotherapy

Guido Kroemer, Xiaolian Deng, Baldur Sveinbjørnsson, Oliver Kepp

10.1080/2162402x.2026.2740845
View Publication

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease

Juan Zafra-Martin, Juan Luis Onieva, Herminda Jimenez-Rodriguez, Beatriz Martinez, Laura Figueroa-Ortiz, Alicia Roman, Rafael Ordoñez, Elisabeth Pérez-Ruiz, Andres Mesas, Jose Miguel Jurado, Barbara Salas, Elisa Salcedo, Rodolfo Chicas-Sett, Antonio Rueda-Dominguez, Isabel Barragan

10.1080/2162402x.2026.2739021
View Publication

Frequently asked questions

How long does it take to publish?

3 days avg. from submission to first decision; 47 days avg. from submission to first post-review decision; 15 days avg. from acceptance to online publication.

Reformat to OncoImmunology using Livewrite Premium

Is a cover letter required?

A cover letter is supported and guidance is provided, but it is not stated as required.

Reformat to OncoImmunology using Livewrite Premium

What are the publication costs?

Article Publishing Charge (APC) may be required for publication. Institutional agreements, discounts, and waivers may reduce or cover the APC.

Reformat to OncoImmunology using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research Immune cells in cancer T-cell and B-cell Immunology Virus-based gene therapy research Monoclonal and Polyclonal Antibodies Research Immune Response and Inflammation Phagocytosis and Immune Regulation Cancer Cells and Metastasis Cancer Research and Treatments RNA Interference and Gene Delivery vaccines and immunoinformatics approaches Chemokine receptors and signaling interferon and immune responses Lymphoma Diagnosis and Treatment Ferroptosis and cancer prognosis Cancer, Stress, Anesthesia, and Immune Response Cytokine Signaling Pathways and Interactions Pancreatic and Hepatic Oncology Research Glioma Diagnosis and Treatment Cancer, Hypoxia, and Metabolism Adenosine and Purinergic Signaling Peptidase Inhibition and Analysis

Related Journals

FO
Frontiers of Medicine Higher Education Press
JG
JCO Global Oncology LIPPINCOTT WILLIAMS & WILKINS
IA
Immunotherapy Advances Oxford University Press
TA
Therapeutic Advances in Medical Oncology SAGE Publishing
TO
Targeted Oncology Adis, Springer Healthcare
JO
Journal of the National Cancer Center Elsevier BV